Related Experiment Videos
Vitamin Analysis Comparison Study
Efrat Fleissig1, Eddie Apenbrinck2, Xiang Zhang3
1Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, USA; Department of Ophthalmology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
American Journal of Ophthalmology
|August 24, 2020
Summary
Dietary supplements for macular degeneration showed accurate vitamin C, vitamin E, zinc, and copper levels. While minor labeling variations exist, they are unlikely to cause toxicity at recommended doses.
Area of Science:
- Nutritional Science
- Ophthalmology
- Analytical Chemistry
Background:
- Macular degeneration is a leading cause of vision loss in older adults.
- Dietary supplements containing vitamins C, E, zinc, and copper are often recommended for patients at risk.
- Ensuring the accuracy of supplement content is crucial for patient safety and therapeutic efficacy.
Purpose of the Study:
- To compare and analyze the concentrations of key nutrients in national and regional dietary supplements.
- To evaluate the accuracy of product labeling for supplements recommended for macular degeneration.
- To assess potential risks associated with nutrient content variations in these supplements.
Main Methods:
- A prospective cross-sectional study design was employed.
- National and generic multivitamin formulations for age-related macular degeneration were procured.
- Vitamin C and E content were analyzed using gas chromatography-mass spectrometry; zinc and copper were analyzed by atomic absorption spectroscopy.
Main Results:
- Most tested supplements, including national brands (tablet and gel capsule) and generic tablets, demonstrated relatively accurate product labeling.
- Measured quantities of vitamin C, vitamin E, zinc, and copper were generally slightly higher than labeled.
- These minor variations were not found to pose a risk of systemic toxicity at recommended dosages.
Conclusions:
- National brand name vitamins and generic tablet formulations can be recommended to patients with a degree of confidence.
- Physicians should be aware that minor inaccuracies in supplement labeling may exist.
- The study supports the use of these supplements, with a note on potential labeling discrepancies.